Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

On International Day of Women and Girls in Science, Dr Bauermeister talks to Oxford Science Blog about her route into research – including a 20-year career break to raise and home-educate her seven children.

Sarah Bauermeister

Dr Sarah Bauermeister is a senior data and science manager at Dementias Platform UK, an MRC-funded project based at Oxford University set up to accelerate research into the diagnosis and treatment of dementia.

Q: How did you get into science?

A: Before having children I completed a degree in sports science in South Africa and was intending to travel, but instead I quickly settled in the UK. Later, while home-schooling my children, I worked towards a further degree in psychology, then a master’s – both through the Open University. I specialised in cognitive neuropsychology, focusing on the neurological changes affecting cognition in older adults, and completed my PhD at Brunel University London focusing on lifestyle and fitness as moderators of cognitive decline. I then completed a postdoctoral position investigating cognitive predictors of falls and frailty at the University of Leeds.

Q: Tell us about your first job in science.

A: After a 20-year period during which I studied while raising and home-educating my seven children, I became an early-career scientist in Leeds with people 20 years younger than me. I’d already had my family by that stage, but I found that many of the younger women around me felt they were in a difficult position in this respect.

Read the full interview on the Oxford Science Blog (University of Oxford) website

Similar stories

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.